Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Growth (Status and Outlook) 2025-2031

October 2025 | 84 pages | ID: GC8B941288A9EN
LP Information

Abstracts

According to this study, the global T Cell Surface Glycoprotein CD3 Epsilon Chain market size will reach US$ million by 2031.

United States market for T Cell Surface Glycoprotein CD3 Epsilon Chain is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for T Cell Surface Glycoprotein CD3 Epsilon Chain is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for T Cell Surface Glycoprotein CD3 Epsilon Chain is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key T Cell Surface Glycoprotein CD3 Epsilon Chain players cover Amgen Inc, Celgene Corp, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, MacroGenics Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the ?T Cell Surface Glycoprotein CD3 Epsilon Chain Industry Forecast? looks at past sales and reviews total world T Cell Surface Glycoprotein CD3 Epsilon Chain sales in 2024, providing a comprehensive analysis by region and market sector of projected T Cell Surface Glycoprotein CD3 Epsilon Chain sales for 2025 through 2031. With T Cell Surface Glycoprotein CD3 Epsilon Chain sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world T Cell Surface Glycoprotein CD3 Epsilon Chain industry.

This Insight Report provides a comprehensive analysis of the global T Cell Surface Glycoprotein CD3 Epsilon Chain landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on T Cell Surface Glycoprotein CD3 Epsilon Chain portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global T Cell Surface Glycoprotein CD3 Epsilon Chain market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for T Cell Surface Glycoprotein CD3 Epsilon Chain and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global T Cell Surface Glycoprotein CD3 Epsilon Chain.

This report presents a comprehensive overview, market shares, and growth opportunities of T Cell Surface Glycoprotein CD3 Epsilon Chain market by product type, application, key players and key regions and countries.

Segmentation by Type:

• ND-007
• Foralumab
• Coltelizumab
• AVA-002
• Others

Segmentation by Application:

• Autoimmune Disorders
• Hepatitis B
• Multiple Sclerosis
• Prostate Cancer
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Amgen Inc
• Celgene Corp
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline Plc
• MacroGenics Inc
• Meridigen Biotech Co Ltd
• Numab Innovation AG
• SYNIMMUNE GmbH
• Tiziana Life Sciences Plc

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2020-2031)
  2.1.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for T Cell Surface Glycoprotein CD3 Epsilon Chain by Country/Region (2020, 2024 & 2031)
2.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Segment by Type
  2.2.1 ND-007
  2.2.2 Foralumab
  2.2.3 Coltelizumab
  2.2.4 AVA-002
  2.2.5 Others
2.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type
  2.3.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Type (2020-2025)
2.4 T Cell Surface Glycoprotein CD3 Epsilon Chain Segment by Application
  2.4.1 Autoimmune Disorders
  2.4.2 Hepatitis B
  2.4.3 Multiple Sclerosis
  2.4.4 Prostate Cancer
  2.4.5 Others
2.5 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application
  2.5.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Application (2020-2025)

3 T CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN MARKET SIZE BY PLAYER

3.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Player
  3.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Player (2020-2025)
  3.1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Player (2020-2025)
3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 T CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN BY REGION

4.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2020-2025)
4.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Annual Revenue by Country/Region (2020-2025)
4.3 Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth (2020-2025)
4.4 APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth (2020-2025)
4.5 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth (2020-2025)
4.6 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2020-2025)
5.2 Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2020-2025)
5.3 Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2020-2025)
6.2 APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2020-2025)
6.3 APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2020-2025)
7.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2020-2025)
7.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain by Region (2020-2025)
8.2 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2020-2025)
8.3 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL T CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN MARKET FORECAST

10.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast by Region (2026-2031)
  10.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast by Region (2026-2031)
  10.1.2 Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.1.3 APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.1.4 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.1.5 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
10.2 Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast by Country (2026-2031)
  10.2.1 United States Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.2.2 Canada Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.2.3 Mexico Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.2.4 Brazil Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
10.3 APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast by Region (2026-2031)
  10.3.1 China T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast
  10.3.2 Japan Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.3.3 Korea Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.3.4 Southeast Asia Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.3.5 India Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.3.6 Australia Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
10.4 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast by Country (2026-2031)
  10.4.1 Germany Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.4.2 France Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.4.3 UK Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.4.4 Italy Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.4.5 Russia Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
10.5 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast by Region (2026-2031)
  10.5.1 Egypt Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.5.2 South Africa Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.5.3 Israel Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
  10.5.4 Turkey Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast
10.6 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast by Type (2026-2031)
10.7 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market T Cell Surface Glycoprotein CD3 Epsilon Chain Forecast

11 KEY PLAYERS ANALYSIS

11.1 Amgen Inc
  11.1.1 Amgen Inc Company Information
  11.1.2 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
  11.1.3 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Amgen Inc Main Business Overview
  11.1.5 Amgen Inc Latest Developments
11.2 Celgene Corp
  11.2.1 Celgene Corp Company Information
  11.2.2 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
  11.2.3 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Celgene Corp Main Business Overview
  11.2.5 Celgene Corp Latest Developments
11.3 F. Hoffmann-La Roche Ltd
  11.3.1 F. Hoffmann-La Roche Ltd Company Information
  11.3.2 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
  11.3.3 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 F. Hoffmann-La Roche Ltd Main Business Overview
  11.3.5 F. Hoffmann-La Roche Ltd Latest Developments
11.4 GlaxoSmithKline Plc
  11.4.1 GlaxoSmithKline Plc Company Information
  11.4.2 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
  11.4.3 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 GlaxoSmithKline Plc Main Business Overview
  11.4.5 GlaxoSmithKline Plc Latest Developments
11.5 MacroGenics Inc
  11.5.1 MacroGenics Inc Company Information
  11.5.2 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
  11.5.3 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 MacroGenics Inc Main Business Overview
  11.5.5 MacroGenics Inc Latest Developments
11.6 Meridigen Biotech Co Ltd
  11.6.1 Meridigen Biotech Co Ltd Company Information
  11.6.2 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
  11.6.3 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Meridigen Biotech Co Ltd Main Business Overview
  11.6.5 Meridigen Biotech Co Ltd Latest Developments
11.7 Numab Innovation AG
  11.7.1 Numab Innovation AG Company Information
  11.7.2 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
  11.7.3 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Numab Innovation AG Main Business Overview
  11.7.5 Numab Innovation AG Latest Developments
11.8 SYNIMMUNE GmbH
  11.8.1 SYNIMMUNE GmbH Company Information
  11.8.2 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
  11.8.3 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 SYNIMMUNE GmbH Main Business Overview
  11.8.5 SYNIMMUNE GmbH Latest Developments
11.9 Tiziana Life Sciences Plc
  11.9.1 Tiziana Life Sciences Plc Company Information
  11.9.2 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
  11.9.3 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Tiziana Life Sciences Plc Main Business Overview
  11.9.5 Tiziana Life Sciences Plc Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. T Cell Surface Glycoprotein CD3 Epsilon Chain Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of ND-007
Table 4. Major Players of Foralumab
Table 5. Major Players of Coltelizumab
Table 6. Major Players of AVA-002
Table 7. Major Players of Others
Table 8. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2020-2025) & ($ millions)
Table 10. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Type (2020-2025)
Table 11. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2020-2025) & ($ millions)
Table 13. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Application (2020-2025)
Table 14. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Player (2020-2025) & ($ millions)
Table 15. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Player (2020-2025)
Table 16. T Cell Surface Glycoprotein CD3 Epsilon Chain Key Players Head office and Products Offered
Table 17. T Cell Surface Glycoprotein CD3 Epsilon Chain Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2020-2025) & ($ millions)
Table 21. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Region (2020-2025)
Table 22. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Country (2020-2025)
Table 26. Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Type (2020-2025)
Table 28. Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Application (2020-2025)
Table 30. APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Region (2020-2025)
Table 32. APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Country (2020-2025)
Table 36. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of T Cell Surface Glycoprotein CD3 Epsilon Chain
Table 42. Key Market Challenges & Risks of T Cell Surface Glycoprotein CD3 Epsilon Chain
Table 43. Key Industry Trends of T Cell Surface Glycoprotein CD3 Epsilon Chain
Table 44. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Amgen Inc Details, Company Type, T Cell Surface Glycoprotein CD3 Epsilon Chain Area Served and Its Competitors
Table 49. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
Table 50. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Amgen Inc Main Business
Table 52. Amgen Inc Latest Developments
Table 53. Celgene Corp Details, Company Type, T Cell Surface Glycoprotein CD3 Epsilon Chain Area Served and Its Competitors
Table 54. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
Table 55. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Celgene Corp Main Business
Table 57. Celgene Corp Latest Developments
Table 58. F. Hoffmann-La Roche Ltd Details, Company Type, T Cell Surface Glycoprotein CD3 Epsilon Chain Area Served and Its Competitors
Table 59. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
Table 60. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. F. Hoffmann-La Roche Ltd Main Business
Table 62. F. Hoffmann-La Roche Ltd Latest Developments
Table 63. GlaxoSmithKline Plc Details, Company Type, T Cell Surface Glycoprotein CD3 Epsilon Chain Area Served and Its Competitors
Table 64. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
Table 65. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. GlaxoSmithKline Plc Main Business
Table 67. GlaxoSmithKline Plc Latest Developments
Table 68. MacroGenics Inc Details, Company Type, T Cell Surface Glycoprotein CD3 Epsilon Chain Area Served and Its Competitors
Table 69. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
Table 70. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. MacroGenics Inc Main Business
Table 72. MacroGenics Inc Latest Developments
Table 73. Meridigen Biotech Co Ltd Details, Company Type, T Cell Surface Glycoprotein CD3 Epsilon Chain Area Served and Its Competitors
Table 74. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
Table 75. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Meridigen Biotech Co Ltd Main Business
Table 77. Meridigen Biotech Co Ltd Latest Developments
Table 78. Numab Innovation AG Details, Company Type, T Cell Surface Glycoprotein CD3 Epsilon Chain Area Served and Its Competitors
Table 79. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
Table 80. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Numab Innovation AG Main Business
Table 82. Numab Innovation AG Latest Developments
Table 83. SYNIMMUNE GmbH Details, Company Type, T Cell Surface Glycoprotein CD3 Epsilon Chain Area Served and Its Competitors
Table 84. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
Table 85. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. SYNIMMUNE GmbH Main Business
Table 87. SYNIMMUNE GmbH Latest Developments
Table 88. Tiziana Life Sciences Plc Details, Company Type, T Cell Surface Glycoprotein CD3 Epsilon Chain Area Served and Its Competitors
Table 89. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offered
Table 90. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Tiziana Life Sciences Plc Main Business
Table 92. Tiziana Life Sciences Plc Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. T Cell Surface Glycoprotein CD3 Epsilon Chain Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Country/Region (2024)
Figure 8. T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Type in 2024
Figure 10. T Cell Surface Glycoprotein CD3 Epsilon Chain in Autoimmune Disorders
Figure 11. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market: Autoimmune Disorders (2020-2025) & ($ millions)
Figure 12. T Cell Surface Glycoprotein CD3 Epsilon Chain in Hepatitis B
Figure 13. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market: Hepatitis B (2020-2025) & ($ millions)
Figure 14. T Cell Surface Glycoprotein CD3 Epsilon Chain in Multiple Sclerosis
Figure 15. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market: Multiple Sclerosis (2020-2025) & ($ millions)
Figure 16. T Cell Surface Glycoprotein CD3 Epsilon Chain in Prostate Cancer
Figure 17. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 18. T Cell Surface Glycoprotein CD3 Epsilon Chain in Others
Figure 19. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market: Others (2020-2025) & ($ millions)
Figure 20. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Application in 2024
Figure 21. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Player in 2024
Figure 22. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Region (2020-2025)
Figure 23. Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2020-2025 ($ millions)
Figure 24. APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2020-2025 ($ millions)
Figure 25. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2020-2025 ($ millions)
Figure 27. Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Value Market Share by Country in 2024
Figure 28. United States T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Region in 2024
Figure 33. APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Type (2020-2025)
Figure 34. APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Application (2020-2025)
Figure 35. China T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 39. India T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Country in 2024
Figure 42. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Type (2020-2025)
Figure 43. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Application (2020-2025)
Figure 44. Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 45. France T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 46. UK T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Application (2020-2025)
Figure 52. Egypt T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 58. APAC T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 59. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 61. United States T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 62. Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 63. Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 64. Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 65. China T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 66. Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 67. Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 69. India T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 70. Australia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 71. Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 72. France T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 73. UK T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 74. Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 75. Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 76. Egypt T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 77. South Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 78. Israel T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 79. Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)
Figure 80. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2026-2031 ($ millions)